MedTrace Logo

Non Interventional Study For Patients Treated With Somavert®

NCT00858143 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 311

Last updated 2009-09-02

Study results available
· View outcomes & findings →

Summary

This open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study was performed in order to examine the efficacy and safety of Somavert® in treatment of subjects with acromegaly and its effects on acromegaly related co-morbidities.

Conditions

Interventions

OTHER

Non Interventional Observation

Post marketing surveillance study = prospective, non-interventional observation of the use of Somavert®

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2008-01-31
Completion
2008-01-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00858143 on ClinicalTrials.gov